Eagle Pharmaceuticals Inc
OTC:EGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eagle Pharmaceuticals Inc
OTC:EGRX
|
US |
|
P
|
Profound Medical Corp
NASDAQ:PROF
|
CA |
|
W
|
Walt Disney Co
F:WDP
|
US |
|
Granite Ridge Resources Inc
F:Y60
|
US |
|
Casa Minerals Inc
XTSX:CASA
|
CA |
|
S
|
Sondrel (Holdings) PLC
LSE:SND
|
UK |
|
Isetan Mitsukoshi Holdings Ltd
OTC:IMHDF
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EGRX's stock price target?
Not Available
EGRX doesn't have any price targets made by Wall Street professionals.
What is Eagle Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the
compound annual growth rate for
Eagle Pharmaceuticals Inc's revenue is
42%.
The projected
CAGR
for the next 3 years is
-10%.
What is Eagle Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-21%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's operating income for the next 3 years is
-21%.
What is Eagle Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
4%
The
compound annual growth rate
of Eagle Pharmaceuticals Inc's net income for the next 3 years is
4%.
